Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Metabolic Syndrome and NAFLD
NCT02496390Phase 2Completed
- Start
- Jun 2016
- Primary completion
- Apr 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in non-alcoholic fatty liver disease (NAFLD), metabolic syndrome. Started Jun 2016; status: completed.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
non-alcoholic fatty liver disease (NAFLD)metabolic syndrome
Beyond the preview
Go deeper on NCT02496390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496390.